What this is
- How it works
- How it works isn't classified yet
- Tested for
- Plaque, Dental Plaque, Gingivitis
- Main trialPhase 3
- “Qualified subjects will be enrolled and randomized to either one of the three study groups described above based on their initial modified gingivitis and plaque scores. Subjects will be instructed to use the products according to the instructions provided. Subjects will return to the dental office for evaluation after three months and six months of product use. All subjects will be followed for adverse events throughout the study.”In the company’s words, NCT07842991 on ClinicalTrials.gov
Other drugs for Plaque
- MeridolColgate Palmolive · Phase 3
- DonanemabEli Lilly · Phase 3
- DarovasertibIDEAYA Biosciences · Phase 2
- GAL-101Galimedix Therapeutics Inc · Phase 2
- ACI-24.060AC Immune SA · Phase 1/2
- 8M2DCenna Biosciences Inc. · Phase 1
Coming up1
- Jan 2027Phase 3 trial completes · ClinicalTrials.gov
Changes0
Last 90 daysNo changes yet. We started recording changes on 6 Nov 2026.
Trials1
| Trial | Phase | Completes | What it tests |
|---|---|---|---|
| Phase 3Recruiting | Jan 2027 | Clinical Evaluation of a Toothpaste for Dental Plaque Reduction and Prevention of Gum Problems |
A trial in both registries shows both numbers.
About
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026